Effects of estradioldrospirenone on ocular and nasal functions in postmenopausal women

Climacteric

Volumn 14, Issue 4, 2011, Pages 482-487

  Coksuer, H ^a   Ozcura, F ^a   Oghan, F ^a   Haliloglu, B ^b   Coksuer, C ^c  

^a DUMLUPINAR UNIVERSITY   (Turkey)

^b MALTEPE UNIVERSITY   (Turkey)

^c CIZRE STATE HOSPITAL   (Turkey)

Author keywords

Angeliq; Drospirenone; Dry eye; Hormone replacement therapy; Nasal airflow; Ocular disease

Indexed keywords

DROSPIRENONE PLUS ESTRADIOL; ESTRADIOL; FOLLITROPIN; ANDROSTANE DERIVATIVE; ESTRADIOL DROSPIRENONE COMBINATION;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRY EYE; ESTRADIOL BLOOD LEVEL; EYE EXAMINATION; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRAOCULAR PRESSURE; MENOPAUSAL SYNDROME; NOSE AIRFLOW; PRIORITY JOURNAL; RHINOMANOMETRY; SCHIRMER TEST; TEAR FILM; TONOMETER; DRUG COMBINATION; ESTROGEN THERAPY; EYE DISEASE; METHODOLOGY; MIDDLE AGED; NOSE OBSTRUCTION; POSTMENOPAUSE; QUESTIONNAIRE;

ANDROSTENES; DRUG COMBINATIONS; DRY EYE SYNDROMES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; EYE DISEASES; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; NASAL OBSTRUCTION; POSTMENOPAUSE; QUESTIONNAIRES; RHINOMANOMETRY;

EID: 79960444173     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2010.539724     Document Type: Article

References (41)

1. Mathers WD, Stovall D, Lane JA, Zimmerman MD, Johnson S. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea 1998;7:353-8 (Pubitemid 28307498)
2. Azzarolo AM, Eihausen H, Schechter J. Estrogen prevention of lacrimal gland cell death and lymphocytic infiltration. Exp Eye Res 2003;77:347-54 (Pubitemid 36952373)
3. Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab 2000;85:4874-82 (Pubitemid 32157680)
4. Smith JA, Vitale S, Reed GF, et al. Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol 2004;122:151-6 (Pubitemid 38176480)
5. Tavani A, La Vecchia C. The adverse effects of hormone replacement therapy. Drugs Aging 1999;14:347-57 (Pubitemid 29213775)
6. Sullivan DA, Wickham LA, Rocha EM, Kelleher RS, da Silveira LA, Toda I. Influence of gender, sex steroid hormones, and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland. Adv Exp Med Biol 1998;438:11-42
7. Wickham A, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000;78:146-53 (Pubitemid 30201420)
8. Caruso S, Serra A, Grillo C, et al. Prospective study evaluating olfactometric and rhinomanometric outcomes in postmenopausal women on 1 mg 17beta-estradiol and 2 mg drospirenone HT. Menopause 2008;15:967-72
9. Caruso S, Roccasalva L, Di Fazio E, et al. Cytological aspects of the nasal respiratory epithelium in postmenopausal women treated with hormone therapy. Fertil Steril 2003;79:543-9
10. Caruso S, Grillo C, Agnello C, Di Mari L, Farina M, Serra A. Olfactometric and rhinomanometric outcome in postmenopausal women treated with hormone therapy: a prospective study. Hum Reprod 2004;19:2959-64 (Pubitemid 40028973)
11. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. J Am Med Assoc 2001;286:2114-19 (Pubitemid 34041596)
12. Archer DF, Thorneycroft IH, Foegh M, et al. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double blind, multicenter trial. Menopause 2005;12:716-27 (Pubitemid 41669124)
13. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000;118:615-21 (Pubitemid 30327337)
14. Klein BE, Klein R, Ritter LL. Is there evidence of estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol 1994;112:85-91 (Pubitemid 24024506)
15. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999;40: 1906-11 (Pubitemid 29365151)
16. Metka M, Enzelsberger H, Knogler W, Schurz B, Aichmair H. Ophthalmic complaints as a climacteric symptom. Maturitas 1991;14:3-8
17. Jensen AA, Higginbotham EJ, Guzinski GM, Davis IL, Ellish NJ. A survey of ocular complaints in postmenopausal women. J Assoc Acad Minor Phys 2000;11:44-9
18. Ozcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm 2007;15:389-93 (Pubitemid 350035478)
19. Johnson ME, Murphy PJ Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index. Invest Ophthalmol Vis Sci 2007;48:4451-8 (Pubitemid 351260959)
20. Toda I, Shimazaki J, Tsubota K. Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis. Ophthalmology 1995;102:302-9
21. Schein OD, Tielsch JM, Munoz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population based perspective. Ophthalmology 1997;104:1395-401 (Pubitemid 28116804)
22. Bonini S, Lambiase A, Schiaoane M, Centofanti M, Palma LA, Bonini S. Estrogen and progesterone receptors in vernal kerato-conjunctivitis. Ophthalmology 1995;102:1374-9
23. Guaschino S, Grimaldi E, Sartore A, et al. Visual function in menopause: the role of hormone replacement therapy. Menopause 2003;10:53-7 (Pubitemid 36706322)
24. Affinito P, Di Spiezio Sardo A, Di Carlo C, et al. Effects of hormone replacement therapy on ocular function in postmeno-pause. Menopause 2003;10:482-7
25. Pelit A, Bagis, Y, Kayaselcuk F, Dursun D, Akova Y, Aydin P. Tear function tests and conjunctival impression cytology before and after hormone replacement therapy in postmenopausal women. Eur J Ophthalmol 2003;13:337-42 (Pubitemid 36693219)
26. Esmaeli B, Harvey JT, Hewlett B. Immunohistochemical evidence for estrogen receptors in meibomian glands. Ophthalmology 2000;107:180-4 (Pubitemid 30210201)
27. Moss SE, Klein R, Klein BE. Prevalence and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264-8
28. Mathers WD, Strovall D, Lane JA, Zimmerman MB. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea 1998;17:353-8 (Pubitemid 28307498)
29. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YK, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998;105:1114-19 (Pubitemid 28268339)
30. Sator MO, Akramian J, Joura EA, et al. Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas 1998;29:93-5 (Pubitemid 28247573)
31. Sano Y. Sexual cycle and intraocular pressure in women. Acta Soc Ophthalmol 1984;68:736-40
32. Qureshi IA. Intraocular pressure: association with menstrual cycle, pregnancy and menopause in apparently healthy women. Chin J Physiol 1995;38:229-34
33. Cumming RG, Mitchell P. Hormone replacement therapy, reproductive factors and cataract.The Blue Mountains Eye Study. Am J Epidemiol 1997;145:242-9 (Pubitemid 27057176)
34. Bigsby RM, Cardenas H, Caperell-Grant A, Grubbs CJ. Protective effects of estrogen in a rat model of age-related cataracts. Proc Natl Acad Sci USA 1999;96:9328-32 (Pubitemid 29374754)
35. Worzala K, Hiller R, Sperduto RD, et al. Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies. Arch Intern Med 2001;161:1448-54 (Pubitemid 32681167)
36. Freeman EE, Munoz B, Schein OD, West SK. Hormone replacement therapy and lens opacities: the Salisbury Eye Evaluation project. Arch Ophthalmol 2001;119:1687-92 (Pubitemid 33035712)
37. Freeman EE, Munoz B, Bressler SB, West SK. Hormone replacement therapy, reproductive factors, age related macular degeneration: the Salisbury Eye Evaluation Project. Ophthalmic Epidemiol 2005;12:37-45 (Pubitemid 41702834)
38. Aina FO, Smeeth L, Hubbard R, Hurt LS, Fletcher AE. Hormone replacement therapy and cataract: a population based case-control study. Eye 2006;20:417-22
39. Velle W. Sex differences in sensory functions. Perspect Biol Med 1987;30:491-523
40. Caruso S, Roccasalva L, Sapienza G, Zappala M, Nuciforo G, Biondi S. Laryngeal cytological aspects in women with surgically induced menopause who were treated with transdermal estrogen replacement therapy. Fertil Steril 2000;74:1073-9
41. Fruzzetti F, Lazzarini V, Ricci C, et al. Effect of an oral contraceptive containing 30 mg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention. Contraception 2007;76:190-4 (Pubitemid 47247660)